A. Teíchmann

ORCID: 0000-0002-3753-129X · 7 papers in corpus · active 1984-2024

Study types

  • article 5
  • review 2

Condition tags

  • endometriosis 5
review 2024
Therapeutic Potential of Natural Resources Against Endometriosis: Current Advances and Future Perspectives.
Drug design, development and therapy ·doi:10.2147/dddt.s464910

Endometriosis (EMS) is defined as the appearance, growth, infiltration, and repeated bleeding of endometrioid tissue (glands and stroma) outside the uterus cavity, which can form nodules and masses. Endometriosis is a chronic inflammatory e…

article 2023
Beneficial biological effects of Flavokawain A, a chalcone constituent from kava, on surgically induced endometriosis rat model
Journal of ethnopharmacology ·doi:10.1016/j.jep.2023.116896
review 2023
Review of the Potential Therapeutic Effects and Molecular Mechanisms of Resveratrol on Endometriosis
International journal of women's health ·doi:10.2147/ijwh.s404660

Endometriosis is a hormone-dependent inflammatory disease characterized by the existence of endometrial tissues outside the uterine cavity. Pharmacotherapy and surgery are the current dominant management options for endometriosis. The great…

article 2022
Synthetic flavokawain analog (E)-1-(2'-hydroxy-4',6'-dimethoxyphenyl)-3-(3-methoxy-4-(3-morpholinopropoxy)phenyl)prop-2-en-1-one (FK-morph) effectively regresses endometriotic implants in rats
European journal of pharmacology ·doi:10.1016/j.ejphar.2022.175240

Endometriosis is an estrogen-dependent inflammatory gynecological disorder that is pathologically defined as the growth of endometrial glands and stroma outside of the uterine cavity. It is estimated that more than 15% of women of reproduct…

article 2008
Patientinnenzentrierte Aspekte der Endometriose
·doi:10.1007/s00129-008-2180-2
article 2003
Patientinnenzentrierte Aspekte der Endometriose
·doi:10.1007/s00129-002-1311-4
article 1984
Lipoproteinveränderungen unter Lynestrenol und Danazol in der hormonellen Behandlung der Endometriose
Geburtshilfe und Frauenheilkunde ·doi:10.1055/s-2008-1036873

The Lipoprotein profile of 24 patients with endometriosis was determined before, during and after the treatment with the two steroid hormones Lynestrenol (10 mg/day) and Danazol (600-800 mg/day). The total cholesterol triglycerides, beta-, …